Literature DB >> 26641965

Signaling pathways regulating Homer1a expression: implications for antidepressant therapy.

Tsvetan Serchov, Rolf Heumann, Dietrich van Calker, Knut Biber.   

Abstract

Homer1a is upregulated by several different antidepressant measures, including non-pharmacological treatments, like sleep deprivation (SD) and electroconvulsive therapy (ECT) and antidepressant drugs, such as imipramine, fluoxetine and ketamine. Homer1a induction might thus be a crucial joint mechanism for antidepressant therapy in general. However, the upstream signaling pathways that regulate or induce Homer1a expression are still not well understood. The main focus of the present review is to offer an overview of the current knowledge about the potential role of Homer1a in depression and the signaling pathways responsible for Homer1a regulation. It is suggested here that a detailed characterization of the signaling mechanisms leading to Homer1a expression might provide novel therapeutic targets for antidepressant drug development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26641965     DOI: 10.1515/hsz-2015-0267

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  9 in total

Review 1.  Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression.

Authors:  Kimberly F Raab-Graham; Emily R Workman; Sanjeev Namjoshi; Farr Niere
Journal:  Brain Res       Date:  2016-04-26       Impact factor: 3.252

Review 2.  Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes.

Authors:  Andrea de Bartolomeis; Elisabetta F Buonaguro; Gianmarco Latte; Rodolfo Rossi; Federica Marmo; Felice Iasevoli; Carmine Tomasetti
Journal:  Front Behav Neurosci       Date:  2017-12-11       Impact factor: 3.558

Review 3.  Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.

Authors:  Samuel Kohtala
Journal:  Pharmacol Rep       Date:  2021-02-20       Impact factor: 3.024

Review 4.  Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.

Authors:  Silvia Pasquini; Chiara Contri; Stefania Merighi; Stefania Gessi; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

5.  Behavioral and Cellular Tagging in Young and in Early Cognitive Aging.

Authors:  Alexandra Gros; Amos W H Lim; Victoria Hohendorf; Nicole White; Michael Eckert; Thomas John McHugh; Szu-Han Wang
Journal:  Front Aging Neurosci       Date:  2022-02-24       Impact factor: 5.750

Review 6.  A Pattern to Link Adenosine Signaling, Circadian System, and Potential Final Common Pathway in the Pathogenesis of Major Depressive Disorder.

Authors:  Xin-Ling Wang; Wilf Gardner; Shu-Yan Yu; Tsvetan Serchov
Journal:  Mol Neurobiol       Date:  2022-08-23       Impact factor: 5.682

7.  Homer1a attenuates glutamate-induced oxidative injury in HT-22 cells through regulation of store-operated calcium entry.

Authors:  Wei Rao; Cheng Peng; Lei Zhang; Ning Su; Kai Wang; Hao Hui; Shu-Hui Dai; Yue-Fan Yang; Peng Luo; Zhou Fei
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

8.  Dlgap1 knockout mice exhibit alterations of the postsynaptic density and selective reductions in sociability.

Authors:  M P Coba; M J Ramaker; E V Ho; S L Thompson; N H Komiyama; S G N Grant; J A Knowles; S C Dulawa
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  Homer1a Attenuates Hydrogen Peroxide-Induced Oxidative Damage in HT-22 Cells through AMPK-Dependent Autophagy.

Authors:  Xiuquan Wu; Peng Luo; Wei Rao; Shuhui Dai; Lei Zhang; Wenke Ma; Jingnan Pu; Yang Yu; Jiu Wang; Zhou Fei
Journal:  Front Neurosci       Date:  2018-02-09       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.